Accepting patients by clinician referral only. Please check with our practice to confirm your insurance eligibility as it may change.
- Clinical Interests
- Mood disorders
- Complementary and alternative medicine
- Medical Education
- MD, Boston University School of Medicine
- PhD, Boston University School of Medicine
- Residency, Massachusetts General Hospital
- Board Certifications
- Foreign Languages
- Boston: Massachusetts General Hospital
- Existing Patients
- Patient Gateway
- Insurances Accepted
- Aetna Health Inc.
- Beech Street
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- BMC HealthNet Mass Health MCO/ACO
- Commonwealth Care Alliance
- Great-West Healthcare (formally One Health Plan)
- Health Care Value Management (HCVM)
- Humana/Choice Care PPO
- Medicare - ACD
- OSW - Maine
- OSW - New Hampshire
- Private Health Care Systems (PHCS)
- Senior Whole Health
- Tufts Health Plan
- United Behavioral Health
- United Behavioral Health - MGH
- Well Sense Pediatrics
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
- Patient Age Group
- Provider Gender
David Mischoulon is the Director of the Depression Clinical and Research Program (DCRP) at Massachusetts General Hospital (MGH), and the Joyce R. Tedlow Professor of Psychiatry at Harvard Medical School. Dr. Mischoulon graduated from the combined MD-PhD program at Boston University School of Medicine in 1994, and interned in medicine at Carney Hospital from 1994-1995. From 1995-1998 he completed his residency in adult psychiatry at MGH, and served as Chief Resident in Psychopharmacology. Dr. Mischoulon's research focuses on various areas of depression, including complementary and alternative medicine. He is also an accredited medical acupuncturist and has studied acupuncture as a treatment for depression. He has received two NARSAD Young Investigator awards, and a K-23 mentored award from NCCAM/NCCIH to study omega-3 fatty acids in the treatment of depression. He has also received R01 and UG3 grants from the NIH and NCCIH to continue his work on omega-3 fatty acids for depression. Dr. Mischoulon has mentored many research fellows and junior faculty, including investigators from Europe, Asia, and Australia, who have gone on to obtain independent funding as principal investigators. Dr. Mischoulon has authored or co-authored more than 250 original articles, review articles, and book chapters. He has co-edited a textbook on natural medications for psychiatric disorders, and more recently an MGH handbook of new treatments for depression. He has been an invited speaker nationally and internationally, and has won several awards, including Distinguished Fellow of the Massachusetts Psychiatric Society and the American Psychiatric Association. Dr. Mischoulon teaches and supervises residents and medical students, and lectures in various MGH Psychiatry Academy continuing medical education courses. He also provides patient care and consultation regarding management of treatment-resistant depression and use of complementary therapies for psychiatric disorders.
A team of psychiatrists at the Massachusetts General Hospital Depression Clinical and Research Program will examine the effect of Bikram Yoga on depression, quality of life, and functioning, in addition to common physiological markers associated with depression.
One Bowdoin Square
Boston, MA 02114-2790